The expression of p-mTOR and COUP-TFII correlates with increased lymphangiogenesis and lymph node metastasis in prostate adenocarcinoma
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 36 (6) , 311.e27-311.e35
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The Chicken Ovalbumin Upstream Promoter-Transcription Factor II Negatively Regulates the Transactivation of Androgen Receptor in Prostate Cancer CellsPLOS ONE, 2012
- Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor CellsCancer Research, 2012
- PI3K/AKT/mTOR Pathway in AngiogenesisFrontiers in Molecular Neuroscience, 2011
- Rapamycin Inhibition of the Akt/mTOR Pathway Blocks Select Stages of VEGF-A 164 –Driven Angiogenesis, in Part by Blocking S6KinaseArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Chicken ovalbumin upstream promoter transcription factor II in human breast carcinoma: Possible regulator of lymphangiogenesis via vascular endothelial growth factor‐C expressionCancer Science, 2009
- mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in MiceCancer Cell, 2009
- The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populationsProceedings of the National Academy of Sciences, 2009
- Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII) regulates growth and patterning of the postnatal mouse cerebellumDevelopmental Biology, 2008
- Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sproutingJournal of Experimental Medicine, 2007
- Prostate carcinoma I: prognostic factors in radical prostatectomy specimens and pelvic lymph nodesBJU International, 2006